Business Description
BRIM Biotechnology Inc
ISIN : TW0006885007
Total Employee Number:
32Description
BRIM Biotechnology Inc is engaged in the research and development of new drug translation, genetic testing services, research and development services in natural and engineering sciences, and medical laboratory services. The Group has two reportable operating segments: BRIM's main business is new drug translational development services, and Compass's main business is gene sequencing and testing technology services. It generates the majority of its revenue from the BRIM segment. Geographically, it operates in Taiwan, Japan, and the USA. It generates the majority of its revenue from Taiwan.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 72.61 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 22.7 | |||||
Beneish M-Score | 10.36 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 81.7 | |||||
3-Year EBITDA Growth Rate | 5.5 | |||||
3-Year EPS without NRI Growth Rate | 4.8 | |||||
3-Year FCF Growth Rate | -28.4 | |||||
3-Year Book Growth Rate | 9.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 56.46 | |||||
9-Day RSI | 47.94 | |||||
14-Day RSI | 46.39 | |||||
3-1 Month Momentum % | 5.99 | |||||
6-1 Month Momentum % | -7.01 | |||||
12-1 Month Momentum % | -21.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 18.06 | |||||
Quick Ratio | 18.05 | |||||
Cash Ratio | 17.31 | |||||
Days Inventory | 63.23 | |||||
Days Sales Outstanding | 27.82 | |||||
Days Payable | 64.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.4 | |||||
Shareholder Yield % | -0.35 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 22.77 | |||||
Operating Margin % | -8250.89 | |||||
Net Margin % | -7949.95 | |||||
EBITDA Margin % | -7419.31 | |||||
FCF Margin % | -5995.83 | |||||
OCF Margin % | -5995.83 | |||||
ROE % | -23.25 | |||||
ROA % | -20.34 | |||||
ROIC % | -79.92 | |||||
3-Year ROIIC % | -43.81 | |||||
ROC (Joel Greenblatt) % | -2946.38 | |||||
ROCE % | -23.5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 530.49 | |||||
PB Ratio | 1.75 | |||||
Price-to-Tangible-Book | 2.7 | |||||
EV-to-EBIT | -4.11 | |||||
EV-to-EBITDA | -4.54 | |||||
EV-to-Revenue | 336.86 | |||||
EV-to-FCF | -5.66 | |||||
Price-to-GF-Value | 0.04 | |||||
| Price-to-Net-Current-Asset-Value | 2.8 | |||||
| Price-to-Net-Cash | 2.94 | |||||
Earnings Yield (Greenblatt) % | -24.32 | |||||
FCF Yield % | -11.38 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BRIM Biotechnology Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 5.49 | ||
| EPS (TTM) (NT$) | -3.32 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.46 | ||
| 3-Year Sortino Ratio | -0.63 | ||
| Volatility % | 25.24 | ||
| 14-Day RSI | 46.39 | ||
| 14-Day ATR (NT$) | 0.863203 | ||
| 20-Day SMA (NT$) | 22.34 | ||
| 12-1 Month Momentum % | -21.68 | ||
| 52-Week Range (NT$) | 20.5 - 39.3 | ||
| Shares Outstanding (Mil) | 133.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BRIM Biotechnology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BRIM Biotechnology Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
BRIM Biotechnology Inc Frequently Asked Questions
What is BRIM Biotechnology Inc(TPE:6885)'s stock price today?
The current price of TPE:6885 is NT$21.75. The 52 week high of TPE:6885 is NT$39.30 and 52 week low is NT$20.50.
When is next earnings date of BRIM Biotechnology Inc(TPE:6885)?
The next earnings date of BRIM Biotechnology Inc(TPE:6885) is .
Does BRIM Biotechnology Inc(TPE:6885) pay dividends? If so, how much?
BRIM Biotechnology Inc(TPE:6885) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on BRIM Biotechnology Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers